Three considerations before advising 5-α-reductase inhibitors for chemoprevention

Patrick C. Walsh

doi:10.1200/JCO.2009.22.9070

Three considerations before advising 5-α-reductase inhibitors for chemoprevention

Patrick C. Walsh

Johns Hopkins Hospital

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	e22
Journal	Journal of Clinical Oncology
Volume	27
Issue number	20
DOIs	https://doi.org/10.1200/JCO.2009.22.9070
State	Published - Jul 10 2009

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2009.22.9070

Cite this

@article{7848e978e6634868b03ff3ec2053c85a,

title = "Three considerations before advising 5-α-reductase inhibitors for chemoprevention",

author = "Walsh, {Patrick C.}",

year = "2009",

month = jul,

day = "10",

doi = "10.1200/JCO.2009.22.9070",

language = "English (US)",

volume = "27",

pages = "e22",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "20",

}

TY - JOUR

T1 - Three considerations before advising 5-α-reductase inhibitors for chemoprevention

AU - Walsh, Patrick C.

PY - 2009/7/10

Y1 - 2009/7/10

UR - http://www.scopus.com/inward/record.url?scp=70249126559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249126559&partnerID=8YFLogxK

U2 - 10.1200/JCO.2009.22.9070

DO - 10.1200/JCO.2009.22.9070

M3 - Letter

C2 - 19487370

AN - SCOPUS:70249126559

SN - 0732-183X

VL - 27

SP - e22

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 20

ER -

Three considerations before advising 5-α-reductase inhibitors for chemoprevention

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this